Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic

Background: Liquid biopsy (LB) captures dynamic genomic alterations (alts) across metastatic colorectal cancer (mCRC) therapy and may complement tissue biopsy (TB). We sought to describe the utility of LB and better understand mCRC biology during therapy. Methods: Thirty-three patients (pts) with mC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghatalia, Pooja, Smith, Chad H., Winer, Arthur, Gou, Jiangtao, Kiedrowski, Lesli A., Slifker, Michael, Saltzberg, Patricia D., Bubes, Nicole, Anari, Fern M., Kasireddy, Vineela, Varshavsky, Asya, Liu, Yang, Ross, Eric A., El-Deiry, Wafik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344461/
https://www.ncbi.nlm.nih.gov/pubmed/30705875
http://dx.doi.org/10.3389/fonc.2018.00652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344461/
https://www.ncbi.nlm.nih.gov/pubmed/30705875
http://dx.doi.org/10.3389/fonc.2018.00652

Ejemplares similares